Primary Tumor Resection With EGFR TKI for Stage IV NSCLC
NCT05215548
·
clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
100
Enrollment
OTHER
Sponsor class
Conditions
NSCLC Stage IV
Interventions
PROCEDURE:
therapeutic thoracic surgery
DRUG:
Afatinib
Sponsor
National Taiwan University Hospital